(Q48700130)

14 February 2018

title

99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor (English)

1 reference

14 February 2018

1 reference

Wang J

1

1 reference

14 February 2018

Jiang YP

2

1 reference

14 February 2018

Liu XD

3

1 reference

14 February 2018

Chen ZP

4

1 reference

14 February 2018

Yang LQ

5

1 reference

14 February 2018

Liu CJ

6

1 reference

14 February 2018

Xiang JD

7

1 reference

14 February 2018

Su HL

8

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 December 2005

1 reference

14 February 2018

Acta Neurologica Scandinavica

published in

1 reference

14 February 2018

volume

112

1 reference

14 February 2018

issue

6

1 reference

14 February 2018

page(s)

380-385

1 reference

14 February 2018

Criteria for diagnosing Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

A clinicopathologic study of 100 cases of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Significance of parkinsonian manifestations in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Caring for the older patient, Part I: The relationship of theory to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Effect of L-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

123I-IPT brain SPECT study in essential tremor and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00517.X

10.1111/J.1600-0404.2005.00517.X

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018